|
LO-1
|
Will be able to explain the general feature of the semi-solid drug delivery system. |
|
LO-2
|
Will be able to explain the general feature of ointments. |
|
LO-3
|
Will be able to explain the general feature of the ointment base. |
|
LO-4
|
Will be able to explain the preparation of the ointment. |
|
LO-5
|
Will be able to define the stability issue in ointments. |
|
LO-6
|
Will be able to define the controls performed on the ointment. |
|
LO-7
|
Will be able to explain the preservation of the ointment. |
|
LO-8
|
Will be able to explain the general feature of the gel. |
|
LO-9
|
Will be able to explain the general feature of the paste. |
|
LO-10
|
Will be able to explain the general feature of the serum. |
|
LO-11
|
Will be able to explain the general feature of soap. |
|
LO-12
|
Will be able to explain the general feature of the plaster. |
|
LO-13
|
Will be able to explain the general feature of the poultice. |
|
LO-14
|
Will be able to explain the general feature of the skin. |
|
LO-15
|
Will be able to explain the purpose of drug application to the skin. |
|
LO-16
|
Will be able to define dermal absorption. |
|
LO-17
|
Will be able to explain general information about medical devices. |
|
LO-18
|
Will be able to explain pharmaceutical product packaging. |
|
LO-19
|
Will be able to explain general information about surgical materials. |
|
LO-20
|
Will be able to define cotton. |
|
LO-21
|
Will be able to define the gauze. |
|
LO-22
|
Will be able to define the bandage. |
|
LO-23
|
Will be able to define the surgical thread. |
|
LO-24
|
Will be able to define the drain. |
|
LO-25
|
Will be able to explain the basic concepts of radiopharmaceutical products. |
|
LO-26
|
Will be able to explain general information about radiopharmaceutical products. |
|
LO-27
|
Will be able to explain general information about pharmaceutical aerosols. |
|
LO-28
|
Will be able to explain the classification of pharmaceutical aerosols. |
|
LO-29
|
Will be able to define the topical aerosol. |
|
LO-30
|
Will be able to define the inhalation aerosol. |
|
LO-31
|
Will be able to explain pharmaceutical aerosol production. |
|
LO-32
|
Will be able to explain pharmaceutical aerosol quality control. |
|
LO-33
|
Will be able to explain general information about rectal, vaginal, and urethral suppositories. |
|
LO-34
|
Will be able to explain the application of medication to the rectal area. |
|
LO-35
|
Will be able to explain the application of medication to the vaginal area. |
|
LO-36
|
Will be able to explain suppository preparation. |
|
LO-37
|
Will be able to explain the quality control of suppositories. |
|
LO-38
|
Will be able to explain drug stability. |
|
LO-39
|
Will be able to explain the degradation reaction of drugs. |
|
LO-40
|
Will be able to explain the drug stability study protocol. |
|
LO-41
|
Will be able to explain the degradation reaction kinetics of drugs. |
|
LO-42
|
Will be able to explain stability issues encountered in drugs. |
|
LO-43
|
Will be able to explain the concept of biopharmaceutics. |
|
LO-44
|
Will be able to explain the concept of pharmacokinetics. |
|
LO-45
|
Will be able to explain the concept of bioequivalence. |
|
LO-46
|
Will be able to explain the general characteristics of semi-solid dosage forms. |
|
LO-47
|
Will be able to define ointments. |
|
LO-48
|
Will be able to define creams. |
|
LO-49
|
Will be able to define gels. |
|
LO-50
|
Will be able to define pastes. |
|
LO-51
|
Will be able to define poultices. |
|
LO-52
|
Will be able to define occlusive preparations. |
|
LO-53
|
Will be able to define sun preparations. |
|
LO-54
|
Will be able to define skin cleansing preparations. |
|
LO-55
|
Will be able to define body odor prevention preparations. |
|
LO-56
|
Will be able to explain shaving preparations. |
|
LO-57
|
Will be able to define skin care preparations. |
|
LO-58
|
Will be able to define hair care preparations. |
|
LO-59
|
Will be able to define skin refreshing preparations. |
|
LO-60
|
Will be able to define medical plaster. |